Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
Apply
Belzutifan & Pembrolizumab
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step